Proteomics

Dataset Information

0

Dietary dodecanedioc acid increases metabolic rate and protects against obesity


ABSTRACT: Reduced metabolic capacity is a hallmark of numerous rare genetic diseases as well as more common disease states such as obesity, diabetes, heart disease, and neurological disorders. However, therapies that stimulate energy metabolism are lacking. Here, we show that substituting ~2/3 of the lipid in a high-fat rodent diet with dodecanedioc acid, a 12-carbon dicarboxylic fatty acid (DC12), increases metabolic rate, reduces body fat, reduces liver fat, and improves glucose tolerance. We observed DC12-specific breakdown products in liver, kidney, muscle, heart, and brain, indicating that oral DC12 escapes first-pass liver metabolism and is metabolized by many tissues. In tissues expressing the a isoform of acyl-CoA oxidase-1 (ACOX1), a key peroxisomal fatty acid oxidation enzyme, DC12 was chain shortened as far as the TCA cycle intermediate succinyl-CoA, which may partially explain the increased metabolic rate. In tissues with low peroxisomal fatty acid oxidation capacity, DC12 was oxidized by mitochondria. DC12 was catabolized even by adipose tissue and cannot be stored intracellularly like other fat sources. Finally, we demonstrate that dicarboxylic acids are a useful alternative energy source to improve metabolic function in a mouse model of long-chain fatty acid oxidation disorders.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Birgit Schilling  

PROVIDER: MSV000092073 | MassIVE | Wed May 31 22:27:00 BST 2023

SECONDARY ACCESSION(S): PXD042602

REPOSITORIES: MassIVE

Similar Datasets

2022-11-25 | GSE207914 | GEO
2019-03-08 | GSE125237 | GEO
2014-01-15 | BIOMD0000000506 | BioModels
2014-01-15 | BIOMD0000000505 | BioModels
2018-04-25 | GSE98214 | GEO
2012-06-14 | E-GEOD-37537 | biostudies-arrayexpress
2023-07-02 | GSE218319 | GEO
2023-07-02 | GSE217992 | GEO
2017-02-09 | GSE66766 | GEO
2021-03-23 | GSE156545 | GEO